Derivation of the sledai. A disease activity index for lupus patients

Arthritis & Rheumatism

Volumn 35, Issue 6, 1992, Pages 630-640

  Bombardier, Claire ^a   Gladman, Dafna D ^a   Urowitz, Murray B ^a   Caron, Dominique ^a   Chang, Chi Hsing ^a   Austin, A ^a   Bell, A ^a   Bloch, Daniel A ^a   Corey, Paul N ^a   Decker, John L ^a   Esdaile, John ^a   Fries, James F ^a   Ginzler, Ellen M ^a   Goldsmith, Charles H ^a   Hochberg, Marc C ^a   Jones, John V ^a   Riche, Nicole G H Le ^a   Liang, Matthew H ^a   Lockshin, Michael D ^a   Muenz, Larry R ^a   Sackett, David L ^a   Schur, Peter H ^a   more..

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE ACTIVITY; HEALTH STATUS; HUMAN; INJURY; MEDICAL RECORD; MODEL; MULTIPLE REGRESSION; PHYSICIAN; PRIORITY JOURNAL; RATING SCALE; REGRESSION ANALYSIS; RELIABILITY; SYSTEMIC LUPUS ERYTHEMATOSUS;

CENTRAL NERVOUS SYSTEM; HUMAN; IMMUNE SYSTEM; INDIVIDUALITY; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MUSCULOSKELETAL SYSTEM; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SKIN; SUPPORT, NON-U.S. GOV'T; VASCULITIS;

EID: 0026777352     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780350606     Document Type: Article

References (26)

1. Preliminary criteria for the classification of systemic lupus erythematosus
2. The 1982 revised criteria for the classification of systemic lupus erythematosus
3. SLE subsets: divide and conquer (editorial)
4. The management of systemic lupus erythematosus
5. Measurement of systemic lupus erythematosus activity in clinical research
6. Consensus methods: characteristics and guidelines for use
7. A decision theoretic methodology for severity index development
8. Developing multiattribute health indexes
9. Suppressor‐cell antibody in systemic lupus erythematosus: possible mechanism for suppressor‐cell dysfunction
10. Venous syndromes and pulmonary embolism in systemic lupus erythematosus
11. Systemic lupus erythematosus and pregnancy
12. Correlation of DNA‐anti‐DNA association rates with clinical activity in systemic lupus erythematosus (SLE)
13. Impaired immunoglobulin M synthesis by peripheral blood lymphocytes in systemic lupus erythematosus: a primary B‐cell defect
14. Correlation between clinical activity of systemic lupus erythematosus and the amounts of DNA in DNA/anti‐DNA antibody immune complexes
15. Heterogeneity of immunoregulatory T‐cell subsets in systemic lupus erythematosus: correlation with clinical features
16. The significance of thrombocytopenia in systemic lupus erythematosus
17. The lupus activity criteria count (LACC)
18. Constructing a complex judgmental model: an index of trauma severity
19. Use of linear models to analyse physician's decisions
20. The NIH Consensus Development Program: a decade later
21. Prognosis in SLE: the effect of variables that change through time (abstract)
22. Impact of SLE disease activity on survival with validation of a disease activity index (abstract)
23. International validation of three disease activity measures in systemic lupus erythematosus (abstract)
24. A cross cultural validation and reliability of three disease activity indices in systemic lupus erythematosus (SLE)